Navigation Links
Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results
Date:2/17/2010

's distribution network into the Cleveland, OH region by means of an agreement with Zaymat Distributors, and consolidation of  its Korean distribution network by entering into a new exclusive "take or pay" agreement with Clebio.  The Korea arrangement is valued at $2.5 million over the three-year term of the agreement.

The Company received in late December 2009 an initial order associated with its new Korean distribution agreement. This order was not shipped before the end of the third quarter and as such the company was unable to recognize the approximately $80,000 in revenue represented by the order in the 2010 third quarter.  The revenue will be recognized in the fourth quarter which ends March 31, 2010.  The $80,000 in revenue is the initial order in the $2.5 million "take or pay" agreement with Clebio.  

During the quarter the Company retained Laidlaw &Company to provide financial advisory and investment banking services and assistance with identification of strategic partners.  Related to that engagement the Company reported that ANPG Lending LLC, the Company's primary note holder, extended the maturity of its note to accommodate the Laidlaw initiative.

The Company also reported continued progress toward the introduction of an environmentally correct geobiocide for use in the oil & gas industry.  Laidlaw & Company efforts are primarily focused on identifying and engaging potential strategic partners for the oil & gas industry.  

About Anpath Group, Incorporated:

Anpath Group, Inc. (Anpath), through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help p
'/>"/>

SOURCE Anpath Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Anpath Group, Inc. Reports Progress in Japanese Market
2. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
3. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
4. Hanger Orthopedic Group, Inc. Reports an Increase of 30.4% in Earnings Per Share, to $0.30, for the Third Quarter 2009 and Raises Its 2009 Guidance
5. Encorium Group, Inc. Completes $1.6 Million Private Placement of Common Stock and Executes Warrant Exchange Agreement; Ends Discussions to Sell Encorium OY
6. Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win;
7. Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
8. Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners
9. Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc.
10. Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
11. Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Nanobiotechnology Applications, ... An increasing use of ... is anticipated. Nanotechnology will be applied at ... formulations for optimal delivery to diagnostic applications ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... , September 2, 2015 BiondVax Pharmaceuticals ... the National Institute of Allergy and Infectious Diseases (NIAID), part ... Department of Health and Human Services (HHS), to launch a ... the United States in the 2015-16 timeframe. The ... candidate, Multimeric-001 (M-001), as a primer vaccine, which would be ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... SHANGHAI, June 21 /PRNewswire-Asia/ -- WuXi ... pharmaceutical, biotechnology, and medical device research and,development outsourcing company ... that Wei-Min Chang has been appointed Vice President of,Operations ... located in the Jinshan chemical industry zone of Shanghai. ...
... Inc. announced on June 16, 2009, that the Company ... each filed a voluntary petition for reorganization under chapter ... United States Bankruptcy Court for the District of Delaware ... to continue to manage and operate their business as ...
... Corp. (TSX, FSE: HBP) today announced that Dr. Heman ... be presenting a scientific poster describing L-DOS47 analytical method ... Scientists ("AAPS") National Biotechnology Conference, which runs from June ... Trade Center in Seattle, Washington. , ...
Cached Biology Technology:WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 2Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 4Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 5
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... , 31 de julho de 2015 ... www.icg-10.org ) será realizada pela BGI de 22-25 de ... . A conferência está celebrando seu 10 ... 2006, a ICG se tornou uma das reuniões mais ... dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... de julio de 2015 La 10 th ... por medio de BGI del 22 al 25 de octubre de ... Este año, la conferencia celebra su décimo aniversario. Desde ... en una de las reuniones anuales más influyentes del mundo ... reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... regularly vomiting hairballs or refusing to eat probably isn,t being ... There is a good chance that the cat is acting ... environment, new research suggests. Healthy cats were just as ... and leave waste outside their litter box in response to ...
... Salt Lake City, December 30, 2010Officials at Huntsman ... that the National Cancer Institute (NCI) has renewed its ... recognizes the outstanding cancer research conducted at HCI, which ... West and is the only NCI-designated Cancer Center within ...
... can result in long waiting times for seriously ill ... illnesses for the next available treatment. In this edition ... Int 2010; 107[50]: 892𔃆), Michael Christ and his ... assessment of emergency patients. Triage provides reliable methods ...
Cached Biology News:Even healthy cats act sick when their routine is disrupted 2Even healthy cats act sick when their routine is disrupted 3Even healthy cats act sick when their routine is disrupted 4Even healthy cats act sick when their routine is disrupted 5National Cancer Institute renews Cancer Center designation for Huntsman Cancer Institute 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: